These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 13200190)

  • 1. [Erythroblastosis problems; Rh antibody titres and serum tocopherol, their relationship to placental histopathology in fetal erythroblastosis; and a contribution to erythroblastosis prophylaxis with vitamin E].
    BECKMANN R; FELDMANN F; SCHUMMELFEDER N
    Dtsch Med Wochenschr; 1954 Jul; 79(31-32):1157-62. PubMed ID: 13200190
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prophylaxis of fetal erythroblastosis by alpha-tocopherol, vitamin E].
    TEN BERGE BS; VAN ASSEN FJ
    Prog Med (Paris); 1949 Nov; 77(22):511-5. PubMed ID: 15407987
    [No Abstract]   [Full Text] [Related]  

  • 3. [Contribution to the Rh problem with special consideration of the total understanding of fetal erythroblastosis].
    SCHEFFLER W
    Z Arztl Fortbild (Jena); 1957 Mar; 51(6):234-8. PubMed ID: 13443368
    [No Abstract]   [Full Text] [Related]  

  • 4. Suramin-restricted blood volume in the placenta of normal and diabetic rats is normalized by vitamin E treatment.
    Nash P; Eriksson UJ
    Placenta; 2007; 28(5-6):505-15. PubMed ID: 16920189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune globulin prophylaxis of erythroblastosis fetalis.
    Roth JB
    Ohio State Med J; 1969 Jun; 65(6):604-5. PubMed ID: 4977461
    [No Abstract]   [Full Text] [Related]  

  • 6. [Histological peculiarities of the placenta in materno-fetal isoimmunization due to Rh factors].
    Capone N; Urbanetti S; Sobrino R; Sobrino S
    Minerva Ginecol; 1982 Mar; 34(3):151-4. PubMed ID: 6806722
    [No Abstract]   [Full Text] [Related]  

  • 7. Some residual problems concerning Rh prophylaxis.
    Finn R
    Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):436-9. PubMed ID: 5003521
    [No Abstract]   [Full Text] [Related]  

  • 8. Histopathological study of placenta in Rh isoimmunization.
    Prabhu SR; Bharucha ZS; Kandalkar MG
    Indian J Pathol Microbiol; 1983 Apr; 26(2):81-8. PubMed ID: 6418646
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of the relationship between hemolytic disease of the newborn and placental changes].
    Rudenko EF
    Vopr Okhr Materin Det; 1970 Jan; 15(1):8-12. PubMed ID: 5454234
    [No Abstract]   [Full Text] [Related]  

  • 10. [Contribution to the ultrastructure of human placental villi in fetal erythroblastosis].
    Widmaier G
    Arch Gynakol; 1969; 207(4):528-38. PubMed ID: 5819503
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antenatal treatment of maternal-fetal Rh incompatibility hemolysis disease].
    Zhao L; Huang X; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 1998 Jul; 33(7):406-8. PubMed ID: 10806699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigations on the influence of Rh immunoglobulin prophylaxis on the immune response to postpartum rubella vaccination (author's transl)].
    Maroni E; Kunz J; Rösli A; Munzinger J
    Geburtshilfe Frauenheilkd; 1975 Nov; 35(11):821-5. PubMed ID: 53168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylaxis of Rh-immunization.
    Br Med J; 1966 Mar; 1(5488):628-9. PubMed ID: 4956043
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of the administration of citrobioflavonoids and vitamin C on antibody titers in Rh-negative isoimmunized pregnant women].
    Morganti G; Gualandri V; Cozzi M; Gianotti G; Vierucci A
    Riv Emoter Immunoematol; 1965; 12(1):19-27. PubMed ID: 4958752
    [No Abstract]   [Full Text] [Related]  

  • 15. [The problem of antibody control during the first days after anti-D prophylaxis].
    Ennker J; Maas DH; Schneider J
    Fortschr Med; 1978 Sep; 96(33):1650-6. PubMed ID: 100401
    [No Abstract]   [Full Text] [Related]  

  • 16. [Problems of Rhesus prophylaxis].
    Baumgarten K
    Med Lab (Stuttg); 1982 Oct; 35(4):115-21. PubMed ID: 6185833
    [No Abstract]   [Full Text] [Related]  

  • 17. Vitamin E is essential for mouse placentation but not for embryonic development itself.
    Jishage K; Tachibe T; Ito T; Shibata N; Suzuki S; Mori T; Hani T; Arai H; Suzuki H
    Biol Reprod; 2005 Nov; 73(5):983-7. PubMed ID: 16014812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [External quality control for anti-D demonstration within the scope of Rh immunoprevention].
    Lahmann N; Brandstädter W
    Zentralbl Gynakol; 1978; 100(4):208-10. PubMed ID: 418599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Rh prophylaxis.
    Woodrow JC
    Haematologia (Budap); 1974; 8(1-4):281-90. PubMed ID: 4218822
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fetal erythroblastosis & prophylactic Rh group examination in pregnant women; review & commentary on the new prophylactic Rh group study in connection with pregnancy tests].
    FREIESLEBEN E; FRIEDENREICH V
    Ugeskr Laeger; 1958 Mar; 120(13):405-11. PubMed ID: 13557081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.